Amlodipine inhibits rat microsomal cytochrome P450‐mediated drug biotransformation
Identifieur interne : 001615 ( Istex/Curation ); précédent : 001614; suivant : 001616Amlodipine inhibits rat microsomal cytochrome P450‐mediated drug biotransformation
Auteurs : Robert K. Drobitch [Canada] ; Roman A. Mclellan [Canada, Suède] ; Kenneth W. Renton [Canada]Source :
- Journal of Pharmaceutical Sciences [ 0022-3549 ] ; 1997-12.
Abstract
Calcium channel antagonists have been shown to inhibit cytochrome P‐450‐mediated metabolism both in vitro and in vivo. The purpose of the present study was to examine the effect of amlodipine on a suite of rat hepatic microsomal cytochrome P‐450 activities to determine the potential for drug interactions. In this study, amlodipine (0.05 and 0.5 mM) decreased CYP1A‐mediated ethoxyresorufin O‐deethylase activity in microsomes prepared from noninduced (56 and 73% inhibition) and pyridine‐induced (30 and 51% inhibition) rats. Amlodipine reduced pentoxyresorufin O‐deethylase activity (a marker for CYP2B) to 15% of control in incubations utilizing microsomes from phenobarbital‐treated rats, but had no effect on this enzyme reaction in noninduced microsomes. The para‐nitrophenol hydroxylase, erythromycin N‐demethylase, and lauric acid ω and ω −1 hydroxylase activities were significantly inhibited by 1 mM amlodipine in both noninduced and induced microsomes. These results suggest that amlodipine inhibits a number of different P450 forms and therefore has the potential to inhibit the metabolism of a large number of drugs.
Url:
DOI: 10.1021/js970188t
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001615
Links to Exploration step
ISTEX:4FB55A44A6B8BF303FD8043D07A0E22319F85788Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Amlodipine inhibits rat microsomal cytochrome P450‐mediated drug biotransformation</title><author><name sortKey="Drobitch, Robert K" sort="Drobitch, Robert K" uniqKey="Drobitch R" first="Robert K." last="Drobitch">Robert K. Drobitch</name><affiliation wicri:level="1"><mods:affiliation>Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H7.</mods:affiliation><country>Canada</country><wicri:regionArea>Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia</wicri:regionArea></affiliation><affiliation><mods:affiliation>Current Address: Department of Pharmaceutical Sciences, Wayne State University, Detroit, MI 48202.</mods:affiliation><wicri:noCountry code="subField">48202.</wicri:noCountry></affiliation></author><author><name sortKey="Mclellan, Roman A" sort="Mclellan, Roman A" uniqKey="Mclellan R" first="Roman A." last="Mclellan">Roman A. Mclellan</name><affiliation wicri:level="1"><mods:affiliation>Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H7.</mods:affiliation><country>Canada</country><wicri:regionArea>Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Current Address: Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.</mods:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Current Address: Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institute, Stockholm</wicri:regionArea></affiliation></author><author><name sortKey="Renton, Kenneth W" sort="Renton, Kenneth W" uniqKey="Renton K" first="Kenneth W." last="Renton">Kenneth W. Renton</name><affiliation wicri:level="1"><mods:affiliation>Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H7.</mods:affiliation><country>Canada</country><wicri:regionArea>Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H7.</mods:affiliation><country>Canada</country><wicri:regionArea>Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4FB55A44A6B8BF303FD8043D07A0E22319F85788</idno><date when="1997" year="1997">1997</date><idno type="doi">10.1021/js970188t</idno><idno type="url">https://api-v5.istex.fr/document/4FB55A44A6B8BF303FD8043D07A0E22319F85788/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001615</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001615</idno><idno type="wicri:Area/Istex/Curation">001615</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Amlodipine inhibits rat microsomal cytochrome P450‐mediated drug biotransformation</title><author><name sortKey="Drobitch, Robert K" sort="Drobitch, Robert K" uniqKey="Drobitch R" first="Robert K." last="Drobitch">Robert K. Drobitch</name><affiliation wicri:level="1"><mods:affiliation>Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H7.</mods:affiliation><country>Canada</country><wicri:regionArea>Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia</wicri:regionArea></affiliation><affiliation><mods:affiliation>Current Address: Department of Pharmaceutical Sciences, Wayne State University, Detroit, MI 48202.</mods:affiliation></affiliation></author><author><name sortKey="Mclellan, Roman A" sort="Mclellan, Roman A" uniqKey="Mclellan R" first="Roman A." last="Mclellan">Roman A. Mclellan</name><affiliation wicri:level="1"><mods:affiliation>Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H7.</mods:affiliation><country>Canada</country><wicri:regionArea>Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Current Address: Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.</mods:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Current Address: Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institute, Stockholm</wicri:regionArea></affiliation></author><author><name sortKey="Renton, Kenneth W" sort="Renton, Kenneth W" uniqKey="Renton K" first="Kenneth W." last="Renton">Kenneth W. Renton</name><affiliation wicri:level="1"><mods:affiliation>Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H7.</mods:affiliation><country>Canada</country><wicri:regionArea>Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H7.</mods:affiliation><country>Canada</country><wicri:regionArea>Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Pharmaceutical Sciences</title><title level="j" type="abbrev">J. Pharm. Sci.</title><idno type="ISSN">0022-3549</idno><idno type="eISSN">1520-6017</idno><imprint><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>New York</pubPlace><date type="published" when="1997-12">1997-12</date><biblScope unit="volume">86</biblScope><biblScope unit="issue">12</biblScope><biblScope unit="page" from="1501">1501</biblScope><biblScope unit="page" to="1503">1503</biblScope></imprint><idno type="ISSN">0022-3549</idno></series><idno type="istex">4FB55A44A6B8BF303FD8043D07A0E22319F85788</idno><idno type="DOI">10.1021/js970188t</idno><idno type="ArticleID">JPS31</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0022-3549</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Calcium channel antagonists have been shown to inhibit cytochrome P‐450‐mediated metabolism both in vitro and in vivo. The purpose of the present study was to examine the effect of amlodipine on a suite of rat hepatic microsomal cytochrome P‐450 activities to determine the potential for drug interactions. In this study, amlodipine (0.05 and 0.5 mM) decreased CYP1A‐mediated ethoxyresorufin O‐deethylase activity in microsomes prepared from noninduced (56 and 73% inhibition) and pyridine‐induced (30 and 51% inhibition) rats. Amlodipine reduced pentoxyresorufin O‐deethylase activity (a marker for CYP2B) to 15% of control in incubations utilizing microsomes from phenobarbital‐treated rats, but had no effect on this enzyme reaction in noninduced microsomes. The para‐nitrophenol hydroxylase, erythromycin N‐demethylase, and lauric acid ω and ω −1 hydroxylase activities were significantly inhibited by 1 mM amlodipine in both noninduced and induced microsomes. These results suggest that amlodipine inhibits a number of different P450 forms and therefore has the potential to inhibit the metabolism of a large number of drugs.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001615 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001615 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:4FB55A44A6B8BF303FD8043D07A0E22319F85788
|texte= Amlodipine inhibits rat microsomal cytochrome P450‐mediated drug biotransformation
}}
| This area was generated with Dilib version V0.6.29. |  |